InflaRx (IFRX) Enterprise Value (2022 - 2025)
InflaRx (IFRX) has disclosed Enterprise Value for 4 consecutive years, with -$36.9 million as the latest value for Q4 2025.
- Quarterly Enterprise Value rose 34.65% to -$36.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$36.9 million through Dec 2025, up 34.65% year-over-year, with the annual reading at -$36.9 million for FY2025, 34.65% up from the prior year.
- Enterprise Value hit -$36.9 million in Q4 2025 for InflaRx, up from -$56.5 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$17.3 million in Q4 2022 to a low of -$97.1 million in Q4 2023.
- Historically, Enterprise Value has averaged -$52.0 million across 4 years, with a median of -$46.7 million in 2024.
- Biggest five-year swings in Enterprise Value: crashed 460.06% in 2023 and later skyrocketed 41.84% in 2024.
- Year by year, Enterprise Value stood at -$17.3 million in 2022, then plummeted by 460.06% to -$97.1 million in 2023, then surged by 41.84% to -$56.5 million in 2024, then skyrocketed by 34.65% to -$36.9 million in 2025.
- Business Quant data shows Enterprise Value for IFRX at -$36.9 million in Q4 2025, -$56.5 million in Q4 2024, and -$97.1 million in Q4 2023.